HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
John D Hainsworth Selected Research
John D Hainsworth Research Topics
Disease
77
Neoplasms (Cancer)
10/2023 - 02/2001
31
Breast Neoplasms (Breast Cancer)
01/2022 - 01/2002
29
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019 - 02/2001
21
Carcinoma (Carcinomatosis)
03/2016 - 03/2002
17
Disease Progression
01/2021 - 04/2003
16
Renal Cell Carcinoma (Grawitz Tumor)
10/2021 - 11/2005
15
Neutropenia
08/2015 - 03/2003
14
Diarrhea
11/2015 - 05/2003
13
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018 - 05/2002
10
Fatigue
10/2012 - 01/2004
10
Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2009 - 02/2002
8
Prostatic Neoplasms (Prostate Cancer)
01/2017 - 03/2006
7
Adenocarcinoma
08/2015 - 04/2005
7
Thrombocytopenia (Thrombopenia)
10/2012 - 03/2003
6
Hypertension (High Blood Pressure)
01/2022 - 05/2005
6
Neoplasm Metastasis (Metastasis)
10/2018 - 06/2005
6
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2015 - 01/2003
5
Exanthema (Rash)
09/2017 - 12/2007
5
Anemia
11/2015 - 01/2010
5
Colorectal Neoplasms (Colorectal Cancer)
06/2012 - 05/2005
5
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2008 - 01/2003
4
Pathologic Complete Response
04/2020 - 07/2002
4
Lung Neoplasms (Lung Cancer)
03/2016 - 05/2003
4
Infections
03/2016 - 10/2011
4
Stomatitis
03/2016 - 12/2011
4
Esophageal Neoplasms (Esophageal Cancer)
07/2012 - 02/2001
4
Nausea
12/2011 - 11/2005
3
Glioblastoma (Glioblastoma Multiforme)
09/2019 - 08/2010
3
Hemorrhage
01/2018 - 05/2005
3
Triple Negative Breast Neoplasms
08/2017 - 08/2015
3
Melanoma (Melanoma, Malignant)
01/2016 - 09/2010
3
Carcinoid Tumor (Carcinoid)
12/2015 - 12/2011
3
Basal Cell Carcinoma (Rodent Ulcer)
06/2015 - 06/2012
3
Ovarian Neoplasms (Ovarian Cancer)
05/2015 - 09/2006
3
Lymphoma (Lymphomas)
04/2015 - 01/2003
3
Hypersensitivity (Allergy)
10/2012 - 05/2010
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2011 - 07/2002
3
Head and Neck Neoplasms (Head and Neck Cancer)
09/2011 - 07/2002
3
Vomiting
10/2010 - 11/2005
3
Brain Neoplasms (Brain Tumor)
03/2010 - 03/2003
Drug/Important Bio-Agent (IBA)
39
Carboplatin (JM8)
FDA Link
Generic
12/2019 - 03/2002
31
Paclitaxel (Taxol)
FDA Link
Generic
08/2017 - 02/2001
30
Bevacizumab (Avastin)
FDA Link
09/2019 - 05/2005
22
Gemcitabine
FDA Link
10/2016 - 02/2001
20
Docetaxel (Taxotere)
FDA Link
01/2019 - 02/2001
16
Rituximab (Mabthera)
FDA Link
08/2015 - 02/2002
14
Everolimus
FDA Link
10/2021 - 05/2010
14
taxane
IBA
04/2020 - 01/2002
12
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2018 - 11/2005
10
ErbB Receptors (EGF Receptor)
IBA
10/2023 - 11/2005
10
Sunitinib (Sutent)
FDA Link
10/2021 - 05/2010
10
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2019 - 06/2003
10
Sorafenib (BAY 43-9006)
FDA Link
11/2017 - 01/2010
9
Trastuzumab (Herceptin)
FDA Link
10/2023 - 10/2008
9
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2021 - 05/2005
9
Doxorubicin (Adriamycin)
FDA Link
Generic
08/2017 - 01/2002
9
Irinotecan (Camptosar)
FDA Link
Generic
08/2012 - 05/2003
8
Prednisone (Sone)
FDA Link
Generic
01/2017 - 06/2003
8
Etoposide (VP 16)
FDA Link
Generic
01/2010 - 05/2002
7
Hormones (Hormone)
IBA
01/2020 - 11/2003
7
Pemetrexed (MTA)
FDA Link
12/2019 - 06/2010
7
Fluorouracil (Carac)
FDA Link
Generic
07/2012 - 01/2002
6
Anthracyclines
IBA
04/2020 - 08/2006
6
Vinorelbine (Navelbine)
FDA Link
Generic
08/2009 - 02/2001
5
Platinum
IBA
01/2018 - 05/2002
5
ixabepilone (BMS 247550)
FDA Link
08/2017 - 10/2012
5
Oxaliplatin (Eloxatin)
FDA Link
Generic
05/2011 - 07/2008
5
Topotecan (Hycamtin)
FDA Link
Generic
05/2011 - 05/2002
5
Gefitinib (Iressa)
FDA Link
01/2010 - 05/2003
4
Taxoids (Taxanes)
IBA
01/2019 - 08/2006
4
HhAntag691
IBA
01/2018 - 06/2012
4
Vincristine (Oncovin)
FDA Link
Generic
08/2015 - 06/2003
4
Capecitabine (Xeloda)
FDA Link
05/2010 - 07/2008
4
Monoclonal Antibodies
IBA
09/2005 - 01/2003
3
pertuzumab
IBA
10/2023 - 09/2006
3
Androgens
IBA
01/2022 - 05/2011
3
Epidermal Growth Factor (EGF)
IBA
01/2018 - 05/2010
3
pegfilgrastim (Neulasta)
FDA Link
01/2018 - 06/2008
3
pazopanib
FDA Link
01/2018 - 09/2013
3
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
03/2016 - 08/2010
3
Octreotide (Sandostatin)
FDA Link
Generic
12/2015 - 12/2011
3
Abiraterone Acetate
IBA
10/2015 - 05/2011
3
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
01/2013 - 09/2008
3
Cytotoxins (Cytolysins)
IBA
10/2012 - 08/2006
3
Temozolomide (Temodar)
FDA Link
Generic
04/2012 - 05/2003
3
Angiogenesis Inhibitors
IBA
08/2011 - 01/2010
3
vinflunine
IBA
11/2010 - 03/2010
3
Epirubicin (Ellence)
FDA Link
Generic
10/2010 - 08/2006
3
Imatinib Mesylate (Gleevec)
FDA Link
11/2009 - 09/2007
2
human ERBB2 protein
IBA
10/2023 - 01/2018
2
Androgen Receptors (Androgen Receptor)
IBA
01/2022 - 09/2012
Therapy/Procedure
58
Therapeutics
10/2023 - 02/2002
42
Drug Therapy (Chemotherapy)
01/2018 - 02/2001
12
Radiotherapy
01/2016 - 02/2001
11
Neoadjuvant Therapy
04/2020 - 06/2008
10
Combination Drug Therapy (Combination Chemotherapy)
01/2018 - 03/2002
6
Castration
01/2017 - 03/2010
5
Combined Modality Therapy
04/2012 - 07/2002
3
Aftercare (After-Treatment)
01/2017 - 05/2010
3
Induction Chemotherapy
09/2011 - 02/2001